Dokter Reseksi glioma terbaik di dunia — TOP 27

Diakui secara internasional untuk reseksi glioma invasif minimal, Dr. Oliver telah memelopori bedah dengan panduan fluoresensi dan teknik robotik di Centro Médico Teknon.

• 50 tahun spesialisasi dalam kasus tumor otak yang kompleks
• Direktur bersama Pusat Tumor Otak di Barcelona
• Melakukan lebih dari 200 prosedur bedah saraf setiap tahun
• Terlatih di Karolinska Institute dan Montreal Neurological Institute
• Presiden European Skull Base Society

Dr. Solak berspesialisasi dalam kasus kanker kompleks, terlatih di Institut Kanker Universitas Hacettepe dan MD Anderson Cancer Center.

• Keahlian dalam kanker payudara, testis, ovarium, paru-paru, dan gastrointestinal
• Pelatihan fellowship di salah satu pusat kanker terkemuka di dunia
• Berpraktik di Hisar Hospital Intercontinental dengan pilihan perawatan canggih

Dr. Dvora Blumental memimpin Layanan Neuro-onkologi di Sourasky Medical Center dengan 30 tahun pengalaman sebagai neuro-onkolog senior.

• Terlatih dalam neuro-onkologi di Memorial Sloan-Kettering Cancer Center
• Mantan direktur Neuro-onkologi di Huntsman Cancer Institute
• Spesialis dalam pengobatan tumor otak di institut onkologi tingkat atas

Profesor Zvi Ram adalah salah satu ahli bedah saraf terbaik di dunia, yang berspesialisasi dalam operasi tumor otak dan teknik bedah saraf inovatif.

• Memimpin Asosiasi Masyarakat Bedah Saraf Eropa (EANS)
• Pakar dalam pemetaan otak dan stimulasi otak dalam (DBS)
• Penerima Penghargaan Borenstein untuk penelitian otak
• Berspesialisasi dalam bedah invasif minimal untuk tumor otak
• Melakukan penelitian tentang terapi berbasis gen untuk kanker otak

Prof. Dr. Alaettin Celik berspesialisasi dalam bedah anak dan urologi anak, dengan pengalaman puluhan tahun di Rumah Sakit Istanbul Florence Nightingale.

• Ketua pendiri Departemen Bedah Anak di Fakultas Kedokteran Istanbul
• Penulis berbagai buku teks bedah anak
• Anggota Masyarakat Bedah Anak Kementerian Kesehatan Turki
• Penelitian dan publikasi ekstensif dalam bedah anak

Dr. Fox memimpin Klinik Hematologi, Onkologi, dan Perawatan Paliatif di pusat kanker interdisipliner bersertifikat di Solingen.

• Spesialis dalam pengobatan komprehensif penyakit tumor
• Pakar kemoterapi, imunoterapi, dan terapi target
• Aktif dalam penelitian biologi molekuler untuk pengobatan kanker
• Anggota masyarakat onkologi Jerman dan Amerika
• Spesialis berkualifikasi di bidang genetika sejak 2016

Profesor Madya Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan saluran pencernaan di Rumah Sakit Universitas Istinye Liv.

• Spesialis Penyakit Dalam dengan pengalaman rumah sakit yang beragam
• Bekerja di Departemen Onkologi dengan fokus pada perawatan kanker yang komprehensif
• Dipromosikan menjadi Profesor Madya pada tahun 2016
• Pendidikan dari Fakultas Kedokteran Universitas Selcuk

Dr. Mustafa Serkan Alemdar membawa pelatihan khusus dan pengalaman bertahun-tahun di bidang onkologi untuk pengobatan glioma.

• Terlatih dalam onkologi medis di Universitas Akdeniz.
• Pengalaman di beberapa rumah sakit terkemuka termasuk Rumah Sakit Universitas Akdeniz dan Rumah Sakit Pelatihan dan Penelitian Antalya.
• Spesialis penyakit dalam sebelum beralih ke onkologi.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Yaacov Lawrence adalah Kepala Onkologi Radiasi di Sheba Medical Center. Beliau memiliki spesialisasi dalam terapi radiasi presisi dan neuro-onkologi. Dr. Lawrence adalah pelopor bedah radio pleksus celiac untuk manajemen nyeri kanker pankreas. Beliau memegang gelar FASTRO, salah satu penghargaan tertinggi di bidang spesialisasi beliau.

• Memimpin Program Kanker Gastrointestinal di Sheba Medical Center.
• Melakukan bedah radio stereotaktik untuk tumor otak dan kanker sistem saraf.
• Penulis lebih dari 280 publikasi ilmiah tentang protokol radiasi yang dipersonalisasi.
• Menyelesaikan pelatihan fellowship onkologi radiasi di Thomas Jefferson University.

Dr. Raj telah melakukan lebih dari 50.000 operasi kanker, dengan fokus pada peningkatan kualitas hidup pasien. Beliau berlatih di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh.

• 30 tahun pengalaman dalam onkologi bedah
• Spesialis Onkologi Bedah Payudara dan Toraks
• Terlibat dalam lebih dari 200 uji klinis
• Profesor untuk subspesialisasi DNB Onkologi Bedah
• Berbagai publikasi internasional dan nasional

Prof. Dr. Gül Alço adalah ahli onkologi radiasi dengan pengalaman sekitar 27 tahun. Beliau menangani kanker payudara, paru-paru, prostat, saluran pencernaan, ginekologi, sistem saraf pusat, kepala dan leher, jaringan lunak, serta tulang dengan radioterapi.

Keahliannya meliputi radioterapi adaptif dan bedah radiasi (radiosurgery). Beliau menggunakan teknik radiasi canggih untuk memberikan perawatan yang dipersonalisasi dan berbasis bukti dalam lingkungan multidisiplin yang berpusat pada pasien.

Prof. Dr. Abdullah Sakin adalah profesor onkologi medis. Beliau menangani tumor padat, termasuk kanker paru-paru, payudara, gastrointestinal, genitourinari, ginekologi, kanker kepala dan leher, serta melanoma.

Beliau memberikan perawatan yang dipersonalisasi dan berbasis bukti. Perawatannya meliputi kemoterapi, terapi target, imunoterapi, terapi hormon, dan onkologi presisi. Beliau telah menulis lebih dari 200 publikasi ilmiah dan berpartisipasi dalam penelitian klinis internasional. Pekerjaan ini memajukan perawatan kanker yang berpusat pada pasien.

Dr. Paweł Grochowicz, MD, PhD, adalah seorang proktologis dengan pengalaman hampir 40 tahun. Beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Beliau menangani wasir, fistula dan abses anus, fisura anus, inkontinensia tinja, dan kista pilonidal. Beliau juga melakukan kolonoskopi dan polipektomi kolorektal.

Dari tahun 1979 hingga 2016, beliau bekerja di Unit Proktologi, Rumah Sakit Solec, sebuah pusat rujukan dan satu-satunya di Polandia. Sejak 2016, beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Di sana, beliau mengembangkan dan menerapkan metode baru serta menjalankan pekerjaan diagnostik, rehabilitasi, penelitian, dan pengajaran. Pusat ini merupakan kantor pusat Klub Koloproktologi Polandia.

Peran akademik dan penelitian: Institut Kedokteran Eksperimental dan Klinis, Akademi Ilmu Pengetahuan Polandia (1979–1997). Penerima beasiswa DAAD di LMU Munich (1983–1984). Rumah Sakit John Hunter, Universitas Newcastle, Australia (1989–1996). Di sana, beliau menjabat sebagai Direktur Unit Penelitian Transplantasi dan Pejabat Ilmiah Utama (1991–1996).

Dr. Przemyslaw Ciesielski adalah seorang ahli bedah umum. Ia menyelesaikan spesialisasi pada tahun 2008. Ia lulus dari Universitas Kedokteran Warsawa pada tahun 1999. Ia meraih gelar Doktor Ilmu Kedokteran pada tahun 2010. Disertasinya mengevaluasi pemeriksaan klinis dan rektoskopi untuk mendiagnosis penyakit kolorektal pada pasien dengan peningkatan risiko kanker kolorektal.

Pelatihan proktologi dan kolorektalnya mencakup kursus formal dan fellowship. Ia menyelesaikan Kursus Proktologi di Rumah Sakit St. Rota di Vercelli pada tahun 2021 dan 2022, serta di Cologne pada tahun 2016. Ia menjalani fellowship klinis dalam Bedah Umum di Universitas Kedokteran Wina pada tahun 2014 dan di Universitas Magdeburg pada tahun 2015. Ia menjalani beberapa fellowship di Departemen Proktologi, Rumah Sakit Solec di Warsawa dari tahun 2005 hingga 2013. Ia menghadiri lokakarya bedah kolorektal tingkat lanjut di Poznan dan Lodz. Ia juga menyelesaikan kursus di Rumah Sakit St. Mark di London, termasuk "Frontiers in Colorectal Diseases" dan "Advanced Colorectal Workshop".